Magnetic Insight Raises $17M Series B to Expand Magnetic Particle Imaging and Monitoring Technology into Clinical Applications

News
2022
2021
Archive

March 3, 2009

ACHAOGEN SIGNS $26.6 MILLION CONTRACT WITH NIAID FOR DEVELOPMENT OF NEW THERAPY TO TREAT RESISTANT STRAINS OF NIAID CATEGORY A AND B PRIORITY PATHOGENS
February 24, 2009

PEARL THERAPEUTICS SECURES $8 MILLION IN DEBT FINANCING
February 9, 2009

ENTREMED PRESENTS INITIAL CLINICAL RESULTS FOR ENMD-2076
February 9, 2009

BIOTECHS BEFRIEND NON-DILUTIVE FUNDS
February 3, 2009

ACHAOGEN INITIATES PHASE 1 TRIAL OF ACHN-490 FOR TREATMENT OF MULTI-DRUG RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS
January 8, 2009

ACHAOGEN RECEIVES ₤4.1 MILLION AWARD FROM THE WELLCOME TRUST TO ADVANCE ITS NEOGLYCOSIDES PORTFOLIO
January 7, 2009

ANAPHORE, INC. ANNOUNCES $25 MILLION SERIES A FINANCING

© 2022 5AM Venture Management LLC